|
注册号: Registration number: |
ChiCTR2200063445 |
|
最近更新日期: Date of Last Refreshed on: |
2023-04-09 10:46:57 |
|
注册时间: Date of Registration: |
2022-09-07 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于人工智能影像组学开发预测脑脊髓海绵状血管畸形基因型及出血风险的决策系统 |
|
Public title: |
Development of a decision-making system based on radiomic features to predict the genotype and hemorrhagic risks of cerebrospinal cavernous malformations |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于人工智能影像组学开发预测脑脊髓海绵状血管畸形基因型及出血风险的决策系统 |
|
Scientific title: |
Development of a decision-making system based on radiomic features to predict the genotype and hemorrhagic risks of cerebrospinal cavernous malformations |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
任健 |
研究负责人: |
张鸿祺 |
|
Applicant: |
Ren Jian |
Study leader: |
Zhang Hongqi |
|
申请注册联系人电话: Applicant telephone: |
+86 13269087795 |
研究负责人电话:
Study leader's |
+86 13601374152 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
renjian1129@126.com |
研究负责人电子邮件: Study leader's E-mail: |
xwzhanghq@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市西城区长椿街45号首都医科大学宣武医院 |
研究负责人通讯地址: |
北京市西城区长椿街45号首都医科大学宣武医院 |
|
Applicant address: |
Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, China |
Study leader's address: |
Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
首都医科大学宣武医院 |
||
|
Applicant's institution: |
Xuanwu Hospital of Capital Medical University |
||
|
研究负责人所在单位: |
首都医科大学宣武医院 |
||
|
Affiliation of the Leader: |
Xuanwu Hospital of Capital Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
临研审[2022]053号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
首都医科大学宣武医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Xuanwu Hospital of Capital Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-04-13 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
北京市西城区长椿街45号首都医科大学宣武医院 |
||
|
Contact Address of the ethic committee: |
Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
首都医科大学宣武医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Xuanwu Hospital of Capital Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
首都医科大学宣武医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
首都卫生发展科研专项项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
Capital’s Funds for Health Improvement and Research |
||||||||||||||||||||||
|
研究疾病: |
中枢神经系统海绵状血管畸形 |
||||||||||||||||||||||
|
Target disease: |
Cavernous malformations of the central nervous system |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
1.建立包含脑脊髓CM大样本多中心临床队列及样本库,收集CM患者临床和影像资料,以及手术切除病变组织的基因测序结果,分析、总结和报告其特点; 2.基于深度学习算法,学习和归纳脑脊髓CM患者不同基因型与影像特点的关联规则。采用数据挖掘方法建模,实现通过脑脊髓CM患者影像特征对基因型及出血风险自动识别及预测; 3.基于转化医学和软件工程理论,开发脑脊髓CM基因型及出血风险多维度预测模型和决策系统。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. To establish a multi-center clinical cohort and sample bank containing large samples of cerebral and spinal cord cavernous malformations, collect the clinical and imaging data of cavernous malformation patients, as well as the gene sequencing results of surgically removed lesion tissues. And to analyze, summarize and report their characteristics; 2. To learn and summarize associations of different genotypes and imaging characteristics of patients with cerebral and spinal cord cavernous malformation based on the deep learning algorithm. The data mining method was used to model and realize the automatic identification and prediction of genotype and bleeding risk through the imaging characteristics of patients with cerebral and spinal cord cavernous malformation; 3. To develop a multi-dimensional prediction model and decision-making system for genotype and hemorrhage risk of cerebral and spinal cord cavernous malformation based on translational medicine and software engineering. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
病变体积过小,考虑手术获取样本量过少者(送检常规病理检查后不足以对标本进行基因测序)。 |
||||||||||||||||||||||
|
Exclusion criteria: |
The size of the lesion is too small, the sample size obtained by surgery is insufficient (insufficient for genetic sequencing after routine pathology examination). |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-09-01 00:00:00至 To 2024-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-09-01 00:00:00 至 To 2024-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
不适用 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
N/A |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
网络平台 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Web-based public database |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表及电?采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form and electronic data capture. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |